214 related articles for article (PubMed ID: 19169330)
1. Intracameral bevacizumab in the treatment of neovascular glaucoma and exudative retinal detachment after brachytherapy in choroidal melanoma.
Vásquez LM; Somani S; Altomare F; Simpson ER
Can J Ophthalmol; 2009 Feb; 44(1):106-7. PubMed ID: 19169330
[No Abstract] [Full Text] [Related]
2. Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity.
dell'Omo R; Kulkarni A; Franks WA
Acta Ophthalmol; 2008 Sep; 86(6):698-700. PubMed ID: 18081905
[No Abstract] [Full Text] [Related]
3. Treatment of iris melanoma and secondary neovascular glaucoma using bevacizumab and plaque radiotherapy.
Bianciotto C; Shields CL; Kang B; Shields JA
Arch Ophthalmol; 2008 Apr; 126(4):578-9. PubMed ID: 18413538
[No Abstract] [Full Text] [Related]
4. Systemic bevacizumab (Avastin) for exudative retinal detachment secondary to choroidal melanoma.
Newman H; Finger PT; Chin KJ; Pavlick AC
Eur J Ophthalmol; 2011; 21(6):796-801. PubMed ID: 21445839
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal triamcinolone versus intravitreal bevacizumab in the treatment of exudative retinal detachment secondary to posterior uveal melanoma.
Parrozzani R; Pilotto E; Dario A; Miglionico G; Midena E
Am J Ophthalmol; 2013 Jan; 155(1):127-133.e2. PubMed ID: 22995029
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal bevacizumab treatment of radiation maculopathy due to brachytherapy in choroidal melanoma.
Ziemssen F; Voelker M; Altpeter E; Bartz-Schmidt KU; Gelisken F
Acta Ophthalmol Scand; 2007 Aug; 85(5):579-80. PubMed ID: 17324216
[No Abstract] [Full Text] [Related]
7. Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma.
Chalam KV; Gupta SK; Grover S; Brar VS; Agarwal S
Eur J Ophthalmol; 2008; 18(2):255-62. PubMed ID: 18320519
[TBL] [Abstract][Full Text] [Related]
8. Intracameral bevacizumab for iris rubeosis.
Grisanti S; Biester S; Peters S; Tatar O; Ziemssen F; Bartz-Schmidt KU;
Am J Ophthalmol; 2006 Jul; 142(1):158-60. PubMed ID: 16815268
[TBL] [Abstract][Full Text] [Related]
9. Anti-VEGF intravitreal bevacizumab for radiation-associated neovascular glaucoma.
Nagendran ST; Finger PT
Ophthalmic Surg Lasers Imaging Retina; 2015 Feb; 46(2):201-7. PubMed ID: 25707045
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab for iris neovascularization following proton beam irradiation for choroidal melanoma.
Yeung SN; Paton KE; Waite C; Maberley DA
Can J Ophthalmol; 2010 Jun; 45(3):269-73. PubMed ID: 20379286
[TBL] [Abstract][Full Text] [Related]
11. In vivo corneal endothelial safety of intracameral bevacizumab and effect in neovascular glaucoma combined with Ahmed valve implantation.
Shin JP; Lee JW; Sohn BJ; Kim HK; Kim SY
J Glaucoma; 2009; 18(8):589-94. PubMed ID: 19826387
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma.
Mason JO; Albert MA; Persaud TO; Vail RS
Retina; 2007 Sep; 27(7):903-7. PubMed ID: 17891015
[TBL] [Abstract][Full Text] [Related]
13. Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma.
Batioğlu F; Astam N; Ozmert E
Int Ophthalmol; 2008 Feb; 28(1):59-61. PubMed ID: 17609852
[TBL] [Abstract][Full Text] [Related]
14. Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection.
Davidorf FH; Mouser JG; Derick RJ
Retina; 2006 Mar; 26(3):354-6. PubMed ID: 16508439
[No Abstract] [Full Text] [Related]
15. Regression of neovascular iris vessels by intravitreal injection of bevacizumab.
Mason JO; Albert MA; Mays A; Vail R
Retina; 2006 Sep; 26(7):839-41. PubMed ID: 16963866
[No Abstract] [Full Text] [Related]
16. Rapid improvement of radiation-induced neovascular glaucoma and exudative retinal detachment after a single intravitreal ranibizumab injection.
Dunavoelgyi R; Zehetmayer M; Simader C; Schmidt-Erfurth U
Clin Exp Ophthalmol; 2007 Dec; 35(9):878-80. PubMed ID: 18173426
[TBL] [Abstract][Full Text] [Related]
17. Trans-scleral local resection of toxic choroidal melanoma after proton beam radiotherapy.
Konstantinidis L; Groenewald C; Coupland SE; Damato B
Br J Ophthalmol; 2014 Jun; 98(6):775-9. PubMed ID: 24568869
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal bevacizumab for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration.
Bom Aggio F; Eid Farah M; Melo GB
Acta Ophthalmol Scand; 2006 Oct; 84(5):713-4. PubMed ID: 16965511
[No Abstract] [Full Text] [Related]
20. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma.
Yazdani S; Hendi K; Pakravan M
J Glaucoma; 2007 Aug; 16(5):437-9. PubMed ID: 17700285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]